Search Results - "Loghin, Monica Elena"

Neuromuscular Weakness Syndromes from Immune Checkpoint Inhibitors: A Case Series and Literature Review by Daher, Ahmad, Matsuoka, Carlos Kamiya, Loghin, Monica Elena, Penas-Prado, Marta, Tummala, Sudhakar

“…Immune checkpoint inhibitors (CPIs) (anti-cytotoxic T-lymphocyte antigen-4, anti-programmed death 1, and anti-programmed death-ligand 1) have transformed the…”
Get full text

Leptomeningeal disease and breast cancer: the importance of tumor subtype by Abouharb, Sausan, Ensor, Joe, Loghin, Monica Elena, Katz, Ruth, Moulder, Stacy L., Esteva, Francisco J., Smith, Benjamin, Valero, Vicente, Hortobagyi, Gabriel N., Melhem-Bertrandt, Amal

“…Breast cancer (BC) is one of the most common tumors to involve the leptomeninges. We aimed to characterize clinical features and outcomes of patients with LMD…”
Get full text

Phase I/II study to evaluate the safety and clinical efficacy of atezolizumab (atezo; aPDL1) in combination with temozolomide (TMZ) and radiation in patients with newly diagnosed glioblastoma (GBM) by Weathers, Shiao-Pei S., Kamiya-Matsuoka, Carlos, Harrison, Rebecca A., Liu, Diane D., Dervin, Shannon, Yun, Cindy, Loghin, Monica Elena, Penas-Prado, Marta, Majd, Nazanin, Yung, W. K. Alfred, O'Brien, Barbara Jane, De Groot, John Frederick

“…Abstract only 2511 Background: Immunotherapy strategies such as PD-1/PD-L1 inhibition may work synergistically with radiation, which is known to increase…”
Get full text

The natural course of hypermutator gliomas by Kamiya-Matsuoka, Carlos, Metrus, Nicholas Robert, Shaw, Kenna Rael, Penas-Prado, Marta, Weathers, Shiao-Pei S., Loghin, Monica Elena, Alfaro-Munoz, Kristin, Yuan, Ying, O'Brien, Barbara Jane, Harrison, Rebecca A., Yung, W. K. Alfred, Meric-Bernstam, Funda, De Groot, John Frederick

“…Abstract only…”
Get full text

Outcomes after hospitalization in patients with recurrent glioblastoma by Barata, Pedro Miguel Coecho, Kamiya-Matsuoka, Carlos, Lee-Kim, Soo, Loghin, Monica Elena, O'Brien, Barbara Jane, Tremont-Lukats, Ivo

“…Abstract only…”
Get full text

Association of clinical phenotype and treatment history with survival in adult brainstem glioblastoma by Nam, Jooyeon, Harrison, Rebecca A., Weathers, Shiao-Pei S., Pillainayagam, Clement, De Groot, John Frederick, Kamiya-Matsuoka, Carlos, Loghin, Monica Elena, Penas-Prado, Marta, Yung, W. K. Alfred, Li, Jing, Ferguson, Sherise D., O'Brien, Barbara Jane

“…Abstract only e13539 Background: Brainstem gliomas are rare, comprising 1-2% of malignant primary brain tumors. Brainstem glioblastoma (bGBM) often poses a…”
Get full text

Phase I factorial study of temozolomide plus memantine, mefloquine, and metformin as post-radiation adjuvant therapy for newly diagnosed glioblastoma by Maraka, Stefania, Groves, Morris D., Mammoser, Aaron Gerald, Melguizo-Gavilanes, Isaac, Conrad, Charles A., Tremont-Lukats, Ivo, Loghin, Monica Elena, O'Brien, Barbara Jane, Puduvalli, Vinay K., Sulman, Erik P., Hess, Kenneth R., Aldape, Kenneth D., Gilbert, Mark R., De Groot, John Frederick, Yung, W. K. Alfred, Penas-Prado, Marta

“…Abstract only…”
Get full text

A phase I/II clinical trial of autologous CMV-specific cytotoxic T cells (CMV-TC) for glioblastoma: Dose escalation results by Penas-Prado, Marta, Rezvani, Katayoun, Weathers, Shiao-Pei S., Zhou, Shouhao, Kamiya-Matsuoka, Carlos, O'Brien, Barbara Jane, Loghin, Monica Elena, Harrison, Rebecca Anne, Pei, Be Lian, Ictech, Sandra, Hunter, Kathy, Yung, W. K. Alfred, De Groot, John Frederick, Shpall, Elizabeth J., Heimberger, Amy B.

“…Abstract only…”
Get full text

A phase I trial everolimus and sorafenib in patients with recurrent high-grade gliomas: Brain Tumor Treatment Collaborative trial 09-01 by Raizer, Jeffrey J., Grimm, Sean Aaron, Penas-Prado, Marta, Tremont-Lukats, Ivo, Yung, W. K. Alfred, Avgeropoulos, Nicholas George, Walbert, Tobias, Loghin, Monica Elena, Gilbert, Mark R.

“…Abstract only…”
Get full text

A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma by Weathers, Shiao-Pei S., Han, Stan Xiaosi, Liu, Diane D, Conrad, Charles A., Gilbert, Mark R., Loghin, Monica Elena, O'Brien, Barbara Jane, Penas-Prado, Marta, Puduvalli, Vinay K., Tremont-Lukats, Ivo, Yung, W. K. Alfred, De Groot, John Frederick

“…Abstract only…”
Get full text

Phase I study of vorinostat combined with isotretinoin and temozolomide in adults with recurrent malignant gliomas by Penas-Prado, Marta, Hess, Kenneth R., Levin, Victor A., De Groot, John Frederick, Colman, Howard, Groves, Morris D., Conrad, Charles A., Loghin, Monica Elena, Hunter, Kathy, Gilbert, Mark R., Yung, W. K. Alfred, Puduvalli, Vinay K.

“…Abstract only…”
Get full text

Leptomeningeal disease and breast cancer: Relationship of outcome and subtype by Abouharb, Sausan, Ensor, Joe, Loghin, Monica Elena, Katz, Ruth, Gonzalez-Angulo, Ana M., Esteva, Francisco J., Moulder, Stacy L., Valero, Vicente, Hortobagyi, Gabriel N., Melhem-Bertrandt, Amal

“…Abstract only 601 Background: Breast cancer (BC) is one of the most common tumors to involve the leptomeninges. Outcome of leptomeningeal disease (LMD) across…”
Get full text

Lenalidomide and irinotecan in adults with recurrent malignant gliomas: Phase I results of the phase I/II trial by Puduvalli, Vinay K., Groves, Morris D., Gilbert, Mark R., Hess, Kenneth R., Kang, Sanghee, Ictech, Sandra, Conrad, Charles A., Loghin, Monica Elena, De Groot, John Frederick, Levin, Victor A., Yung, W. K. Alfred

“…Abstract only 2036 Background: Patients with recurrent malignant gliomas have limited treatment options. We previously reported promising results using 6 month…”
Get full text

Randomized phase II 8-arm factorial study of adjuvant dose-dense (dd) temozolomide (TMZ) with permutations of thalidomide (Thal), isotretinoin (CRA), and/or celecoxib (Cel) for newly diagnosed glioblastoma (GBM) by Gilbert, Mark R., Hess, Kenneth R., Lagrone, Lore, Groves, Morris D., Levin, Victor A., De Groot, John Frederick, Loghin, Monica Elena, Puduvalli, Vinay K., Fisch, Michael, Giglio, Pierre, Colman, Howard, Conrad, Charles A., Aldape, Kenneth D., Yung, W. K. Alfred

“…Abstract only 2003 Background: Concurrent radiation and TMZ followed by 6-12 months of adjuvant TMZ (d 1-5 of a 28d cycle) is the current standard of care for…”
Get full text

Phase I lead-in to a 2x2x2 factorial trial of dose-dense temozolomide, memantine, mefloquine, and metformin as postradiation adjuvant therapy of glioblastoma (GBM) by Penas-Prado, Marta, Groves, Morris D., Mammoser, Aaron G., Melguizo, Isaac, De Groot, John Frederick, Conrad, Charles A., Tremont-Lukats, Ivo, Loghin, Monica Elena, Puduvalli, Vinay K., Sulman, Erik P., Hess, Kenneth R., Aldape, Kenneth D., Gilbert, Mark R., Yung, W. K. Alfred

“…Abstract only TPS2106 Background: Treatment for GBM is an area of unmet need. Despite optimal therapy, survival is poor and 2nd line therapies are scarce…”
Get full text

BTTC08-01: A phase II study of bevacizumab and erlotinib after radiation therapy and temozolomide in patients with newly diagnosed glioblastoma (GBM) without MGMT promoter methylation by Raizer, Jeffrey J., Giglio, Pierre, Hu, Jethro Lisien, Groves, Morris D., Merrell, Ryan, Conrad, Charles A., Phuphanich, Surasak, Puduvalli, Vinay K., Loghin, Monica Elena, Paleologos, Nina, Yung, W. K. Alfred, Vaillant, Brian D., Rudnick, Jeremy David, Chamberlain, Marc C., Vick, Nicholas, Grimm, Sean Aaron, Tremont-Lukats, Ivo, De Groot, John Frederick, Aldape, Kenneth D., Gilbert, Mark R.

“…Abstract only 2019^ Background: Patients (pts) with GBM with unmethylated MGMT have a worse prognosis than those with methylated MGMT. Novel approaches for…”
Get full text

Quality of life (QOL) and cognitive status among irradiated brain tumor survivors treated with donepezil or placebo by Case, Doug, Naughton, Michelle Joy, Stieber, Volker W., Bayer, Gerald K., Bilodeau, Paul A., Moore, Dennis Frederic, Falchuk, Steven Charles, Needles, Burton M., Piephoff, James, Edenfield, William Jeffery, Giguere, Jeffrey K., Erickson, Nicholette, Loghin, Monica Elena, Shaw, Edward G., Rapp, Stephen R.

“…Abstract only 2051 Background: Cognitive problems after cancer therapy can decrease QOL. This phase III randomized trial tested the effect of donepezil (5-10…”
Get full text

Phase III randomized, double-blind, placebo-controlled trial of donepezil in irradiated brain tumor survivors by Rapp, Stephen R., Case, Doug, Peiffer, Ann, Naughton, Michelle Joy, Stieber, Volker W., Bayer, Gerald K., Bilodeau, Paul A., Moore, Dennis Frederic, Falchuk, Steven Charles, Needles, Burton M., Piephoff, James, Edenfield, William j, Giguere, Jeffrey K., Erickson, Nicholette, Loghin, Monica Elena, Shaw, Edward G.

“…Abstract only 2006 Background: This RCT assessed the effect of 24 weeks of 5-10 mg per day of donepezil, an acetyl cholinesterase inhibitor, on cognitive…”
Get full text